Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Veracyte Inc (NASDAQ:VCYT)

7.21
Delayed Data
As of 1:21pm ET
 -0.03 / -0.41%
Today’s Change
4.21
Today|||52-Week Range
8.15
+0.14%
Year-to-Date
No recent news for Veracyte Inc.

Today’s Trading

Previous close7.24
Today’s open7.19
Day’s range7.17 - 7.27
Volume5,761
Average volume (3 months)68,861
Market cap$201.7M
Dividend yield--
Data as of 1:21pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+4.41%
Earnings growth (this year)-12.97%
Earnings growth (next 5 years)--
Revenue growth (last year)+29.62%
P/E ratioNM
Price/Sales3.78
Price/Book3.91

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd-0.03-0.38%
OXFDOxford Immunotec Glo...0.000.00%
TRILTrillium Therapeutic...+0.16+1.08%
LNTHLantheus Holdings In...+0.02+0.24%
Data as of 1:55pm ET, 09/27/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$49.5M
Annual profit (last year)-$33.7M
Net profit margin-68.08%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bonnie H. Anderson
Chief Operating Officer
Christopher M. Hall
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs